In Situ Reprogramming of Tumor‐Associated Macrophages with Internally and Externally Engineered Exosomes
Angewandte Chemie International Edition · 06.03.2023 · 62 (11)
DOI: 10.1002/anie.202217089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 07.02.2023. Verfasst von Lingmin Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engin…. Hauptthemen laut MEDLINE: Exosomes, Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
The reprogramming of tumor‐associated macrophages (TAMs) has emerged as an efficient strategy for immunotherapy. However, most of the approaches did not allow the in situ reprogramming of TAM because their low efficiency, non‐specificity, or potential side effects. Herein, we produced exosomes with the clustered regularly interspaced short palindromic repeats interference (CRISPRi) internally engineered and the TAM specific peptide externally engineered onto the exosome membrane. The i nternally and e xternally e ngineered e xosomes ( IEEE , also named as I3E ) allowed the selective homing to tumor tissue and targeted to M2‐like TAMs, which nearly repressed the expression of PI‐3 kinase gamma (PI3Kγ) completely, and induced the TAMs polarizing to M1 both in vitro and in vivo. The polarized M1 macrophages awakened the “hot” tumor‐immunity, causing the increase of T lymphocyte infiltration and the decrease of myeloid‐derived suppressor cells, and inhibiting the tumor growth significantly. I3E reprogramed TAMs in situ precisely and efficiently.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, No. 1088 Xueyua…
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliat…
ORCID-Profile: Xingyu Jiang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Program
- Chinese Academy of Sciences
- Shenzhen Bay Laboratory
- Guangdong Province Introduction of Innovative R&D Team
- Tencent
Zitieren
APA
Zhang, L., Lin, Y., Li, S., Guan, X., & Jiang, X. (2023). In Situ Reprogramming of Tumor‐Associated Macrophages with Internally and Externally Engineered Exosomes. Angewandte Chemie International Edition, 62(11). https://doi.org/10.1002/anie.202217089
Vancouver
Zhang L, Lin Y, Li S, Guan X, Jiang X. In Situ Reprogramming of Tumor‐Associated Macrophages with Internally and Externally Engineered Exosomes. Angewandte Chemie International Edition. 2023;62(11). doi:10.1002/anie.202217089
BibTeX
@article{Zhang2023,
author = {Zhang, Lingmin and Lin, Yinshan and Li, Songpei and Guan, Xiaoling and Jiang, Xingyu},
title = {In Situ Reprogramming of Tumor‐Associated Macrophages with Internally and Externally Engineered Exosomes},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {11},
doi = {10.1002/anie.202217089}
}
EUVIMED